Sanofi is to pay Ablynx up to €2.4 billion to develop drugs for immune-related inflammatory diseases based on the biotech’s nanobody technology. The Paris-headquartered pharma firm is suffering from ...

When the chemical division of SCG needed to solve a complex manufacturing problem, its leaders made a bold choice: collaborate with Microsoft and use artificial intelligence to supplement its own ...